PTCA藥物塗層球囊(DCB)導管市場:開發平台報告(開發階段，市場區隔，地區·國家，法規途徑，主要企業)，2024年最新版

藥物塗層球囊（DCB）導管是一種抗再狹窄藥物塗層PTCA球囊導管，旨在預防冠狀動脈再狹窄。 DCB 導管提供快速、短期、均勻和局部的藥物輸送。 DCB 導管可保留血管解剖結構，促進血管癒合，並減少長期雙重抗血小板治療的需要，且不會留下金屬

本報告提供PTCA藥物塗層球囊(DCB)導管市場相關調查，提供產品概要與正在開發的開發中產品趨勢，各種處於開發階段的產品的比較分析和進行中的臨床試驗相關資訊，參與企業的最近的趨勢等資訊。

目錄

第1章 目錄

第2章 簡介

• PTCA藥物塗層球囊(DCB)導管概要

第3章 開發中的產品

• PTCA藥物塗層球囊(DCB)導管 - 各開發階段平台產品
• PTCA藥物塗層球囊(DCB)導管 - 各地區開發中產品
• PTCA藥物塗層球囊(DCB)導管 - 各法規途徑開發中產品
• PTCA藥物塗層球囊(DCB)導管 - 估計核准日開發中產品
• PTCA藥物塗層球囊(DCB)導管 - 進行中的臨床試驗

第4章 PTCA藥物塗層球囊(DCB)導管- 各公司正在開發的開發中產品

• PTCA藥物塗層球囊(DCB)導管企業- 各開發階段的開發中產品
• PTCA藥物塗層球囊(DCB)導管- 各開發階段的開發中產品

第5章 PTCA藥物塗層球囊(DCB)導管的企業和產品概要

• Aachen Resonance GmbH
• Acotec Scientific Co Ltd
• Advanced NanoTherapies Inc
• B. Braun Interventional Systems Inc
• Boston Scientific Corp
• Caliber Therapeutics, Inc.
• Chansu Vascular Technologies LLC
• Concept Medical Inc
• Cordis US Corp
• Dongguan TT Medical Inc
• Innova Vascular Inc
• Jiwei Medical System Ltd
• Lepu Medical Technology(北京)Co Ltd
• Lifetech Scientific (Shenzhen) Co Ltd
• Medtronic Plc
• MicroPort Scientific Corp
• OrbusNeich
• Orchestra BioMed Inc
• QT Vascular Ltd
• Rontis Hellas SA
• Shanghai MicroPort Medical Group Co Ltd
• Shanghai XinZhi Medical Technology Co Ltd
• Shenzhen Salubris Pharmaceuticals Co Ltd
• Spectranetics Corp
• Vascular Nanotransfer Technologies

第6章 PTCA藥物塗層球囊(DCB)導管- 最近的開發

第7章 附錄

• 調查手法
• 關於GlobalData
• 諮詢方式
• 免責聲明

GlobalData's Medical Devices sector report, "PTCA Drug Coated Balloon (DCB) Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the PTCA Drug Coated Balloon (DCB) Catheters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

A Drug Coated Balloon (DCB) Catheter is an anti-restenotic drug coated PTCA balloon catheter intended to prevent re-narrowing of the coronary arteries. DCB Catheters provide fast, short-term, homogenous, local drug delivery. DCB catheters preserve the anatomy of the vessel, promote enhanced vessel healing, and reduce the need for prolonged dual anti-platelet therapy without leaving any metal behind.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the PTCA Drug Coated Balloon (DCB) Catheters under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of PTCA Drug Coated Balloon (DCB) Catheters and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of PTCA Drug Coated Balloon (DCB) Catheters under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 PTCA Drug Coated Balloon (DCB) Catheters Overview

3 Products under Development

• 3.1 PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products by Stage of Development
• 3.2 PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products by Territory
• 3.3 PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products by Regulatory Path
• 3.4 PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products by Estimated Approval Date
• 3.5 PTCA Drug Coated Balloon (DCB) Catheters - Ongoing Clinical Trials

4 PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products under Development by Companies

• 4.1 PTCA Drug Coated Balloon (DCB) Catheters Companies - Pipeline Products by Stage of Development
• 4.2 PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products by Stage of Development

5 PTCA Drug Coated Balloon (DCB) Catheters Companies and Product Overview

• 5.1 Aachen Resonance GmbH Company Overview
  • 5.1.1 Aachen Resonance GmbH Pipeline Products & Ongoing Clinical Trials Overview
• 5.2 Acotec Scientific Co Ltd Company Overview
  • 5.2.1 Acotec Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.3 Advanced NanoTherapies Inc Company Overview
  • 5.3.1 Advanced NanoTherapies Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.4 B. Braun Interventional Systems Inc Company Overview
  • 5.4.1 B. Braun Interventional Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.5 Boston Scientific Corp Company Overview
  • 5.5.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.6 Caliber Therapeutics, Inc. Company Overview
  • 5.6.1 Caliber Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
• 5.7 Chansu Vascular Technologies LLC Company Overview
  • 5.7.1 Chansu Vascular Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.8 Concept Medical Inc Company Overview
  • 5.8.1 Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.9 Cordis US Corp Company Overview
  • 5.9.1 Cordis US Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.10 Dongguan TT Medical Inc Company Overview
  • 5.10.1 Dongguan TT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.11 Innova Vascular Inc Company Overview
  • 5.11.1 Innova Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.12 Jiwei Medical System Ltd Company Overview
  • 5.12.1 Jiwei Medical System Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.13 Lepu Medical Technology (Beijing) Co Ltd Company Overview
  • 5.13.1 Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.14 Lifetech Scientific (Shenzhen) Co Ltd Company Overview
  • 5.14.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.15 Medtronic Plc Company Overview
  • 5.15.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
• 5.16 MicroPort Scientific Corp Company Overview
  • 5.16.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.17 OrbusNeich Company Overview
  • 5.17.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview
• 5.18 Orchestra BioMed Inc Company Overview
  • 5.18.1 Orchestra BioMed Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.19 QT Vascular Ltd Company Overview
  • 5.19.1 QT Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.20 Rontis Hellas SA Company Overview
  • 5.20.1 Rontis Hellas SA Pipeline Products & Ongoing Clinical Trials Overview
• 5.21 Shanghai MicroPort Medical Group Co Ltd Company Overview
  • 5.21.1 Shanghai MicroPort Medical Group Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.22 Shanghai XinZhi Medical Technology Co Ltd Company Overview
  • 5.22.1 Shanghai XinZhi Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.23 Shenzhen Salubris Pharmaceuticals Co Ltd Company Overview
  • 5.23.1 Shenzhen Salubris Pharmaceuticals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.24 Spectranetics Corp Company Overview
  • 5.24.1 Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.25 Vascular Nanotransfer Technologies Company Overview
  • 5.25.1 Vascular Nanotransfer Technologies Pipeline Products & Ongoing Clinical Trials Overview

6 PTCA Drug Coated Balloon (DCB) Catheters- Recent Developments

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us
• 7.4 Disclaimer

List of Tables

• PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products by Stage of Development
• PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products by Territory
• PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products by Regulatory Path
• PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products by Estimated Approval Date
• PTCA Drug Coated Balloon (DCB) Catheters - Ongoing Clinical Trials
• PTCA Drug Coated Balloon (DCB) Catheters Companies - Pipeline Products by Stage of Development
• PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products by Stage of Development
• Glossary

List of Figures

• PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products by Stage of Development
• PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products by Territory
• PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products by Regulatory Path
• PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products by Estimated Approval Date
• PTCA Drug Coated Balloon (DCB) Catheters - Ongoing Clinical Trials